Histamine2 (H2)-Receptor Antagonists in the Treatment of Urticaria

Drugs

Volumn 37, Issue 3, 1989, Pages 345-355

  Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; AMITRIPTYLINE; ASTEMIZOLE; AZATADINE; CHLORPHENIRAMINE; CIMETIDINE; CROMOGLYCATE DISODIUM; DOXEPIN; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; OXATOMIDE; RANITIDINE; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT;

HUMAN; REVIEW; URTICARIA; ANGIONEUROTIC EDEMA; CLINICAL ARTICLE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEDATION; SIDE EFFECT;

HISTAMINE H2 ANTAGONISTS; HUMAN; SUPPORT, NON-U.S. GOV'T; URTICARIA;

EID: 0024477424     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198937030-00004     Document Type: Review

References (117)

1. 3) of histamine receptor
2. 2-receptor antagonists on delayed hypersensitivity
3. 2-antagonist
4. Airway neuropeptides and asthma
5. The effects of astemizole on histamine-induced weal and flare
6. Comparison of oxatomide and clemastine in the treatment of chronic urticaria: a double blind study
7. Urticaria
8. 1 antagonist for the treatment of chronic idiopathic urticaria
9. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria
10. Effect of ketotifen in urticaria factitia and urticaria cholinergica in a cross-over double blind trial
11. Treatment of chronic idiopathic urticaria with terfenadine
12. Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action
13. Neurotensin alters cutaneous vascular permeability and stimulates histamine release from isolated skin
14. 1-receptor antagonist
15. 2 receptor antagonists on the dermographic response
16. Lack of effect of cimetidine in chronic-idiopathic urticaria
17. Evaluation of six antihistamines in vitro and in patients with urticaria
18. Centennial paper: beta dimethylaminoethyl benzhydryl ether hydroxhloride (benadryl) in the treatment of urticaria
19. Inhibition by cromolyn Na, promethazine and cyproheptadine of histamine release from peritoneal cells induced by antigen, 48/80 or A23187
20. 2 antagonists: a cross-over double blind long-term study
21. Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall
22. 2 antagonists: a case report
23. Successful treatment of chronic idiopathic urticaria and angioedema with cimetidine alone
24. Combined cold- and heat-induced cholinergic urticaria
25. Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study
26. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells
27. Neuropeptides and the pathogenesis of allergy
28. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials
29. Basophils and mast cells: insights into their biology, secretory patterns, and function
30. Neuropeptide regulation of the expression of immediate hypersensitivity
31. Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymmetry
32. Efficacy of doxepin in the treatment of chronic idiopathic urticaria
33. Double-blind cross-over study comparing doxepin with diphenhydramine for the treatment of chronic urticaria
34. Inhibition of noncytotoxic histamine liberation from isolated mast cells by antihistamines in rats
35. Doxepin in the treatment of chronic urticaria
36. A controlled trial of therapy in chronic urticaria
37. Detection of histamine receptors at cellular level
38. H-2 histamine receptors
39. Prevention of mast-cell degranulation by ketotifen in patients with physical urticarias
40. 3) of histamine receptors of perivascular nerve terminals
41. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema
42. Effects of infused histamine: analysis of the effects of H-1 histamine receptor antagonist on cardiovascular and pulmonary responses
43. Chronic urticaria: possible causes, suggested treatment alternatives
44. Exercise-induced hives
45. 2 antagonists versus cold induced histamine release
46. Successful treatment of cold angio-oedema by H2-antihistamine therapy
47. 1-receptor-active histamine not sole cause of chronic idiopathic urticaria
48. The effect of terfenadine on dermographic wealing
49. A comparison of astemizole and chlorpheniramine in dermographic urticaria
50. 1 antihistaminic astemizole with special reference to the time of onset of effect and maximum effect
51. Pharmacological studies on nonimmunologic contact urticaria in guinea pigs
52. 2 antihistamines on ‘allergic’ histamine and its inhibition by histamine
53. Cold urticaria
54. 2 antagonists
55. Chronic idiopathic urticaria: the dilemma of treatment
56. The urticarias: current concepts in pathogenesis and treatment
57. Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reactions
58. High affinity benzodiazepine receptors on rat peritoneal mast cells and RBL-1 cells: binding characteristics and effects on granule secretion
59. Treatment of urticaria
60. 2 antihistamine therapy in chronic urticaria
61. In vivo demonstration of inflammatory mediator release following nasal challenge with antigen
62. Comparison of cinnarizine, cyproheptadine, doxepin and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin
63. Antihistamine therapy of chronic urticaria: results of a multicenter study with azatadine and terfenadine
64. Suggestive evidence for a direct innervation of mucosal mast cells
65. 1-histaminergic activation of catecholamine release by chromaffin cells
66. Modulation of the mast cell and inhibition of its mediators: newer antihistaminic agents
67. Terfenadine and brompheniramine maleate in urticaria and dermographism
68. Histamine-containing neurons in the rat hypothalamus
69. Comparison of astemizole and terfenadine in the treatment of chronic urticaria: a randomized double-blind study of 40 patients
70. Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind study in 45 patients
71. 2 antihistamines: results of clinical and experimental studies
72. 2-receptor antagonists
73. Neuroimmunology
74. Ketotifen in the treatment of chronic urticaria and angioneurotic edema
75. The development of a new antihistamine: astemizole
76. Inhibition of mast cell degranulation and histamine release by arylalkylamines
77. 2 blockers on chronic urticaria
78. Oxatomide: a review of its pharmacodynamic properties and therapeutic efficacy
79. Astemizole
80. 2 receptors in human vasculature
81. Total review of all results collected world wide with astemizole
82. Stress and illness
83. Cimetidine treatment of recalcitrant acute allergic urticaria
84. Inhibition of suppressor T lymphocytes (Ts) by cimetidine
85. Cimetidine increases the plasma concentration of hydroxyzine
86. Effect of ketotifen and oxatomide on histamine liberation due to exposure in cold urticaria
87. Properties and roles of the three subclasses of histamine receptors in brain
88. Current concepts: mediators of immediate hypersensitivity reactions
89. Clinical and therapeutical aspects of cold urticaria (urticaria and frigore)
90. Commentary: antihistamines and the treatment of urticaria
91. 2-blockers in chronic urticaria
92. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery
93. Psychoneuroendocrinological effects on the immune response
94. Terfenadine
95. Oral disodium cromoglycate in the treatment of systemic mastocytosis
96. Stress and immunomodulation: the role of depression and neuroendocrine function
97. Pharmacologic modulation of whealing response to histamine in human skin: identification of doxepin as a potent inhibitor
98. Delayed pressure urticaria
99. Allergy and antihistamines: a new riddle
100. Differential release of serotonin and histamine from mast cells
101. Somatostatin induces secretion from rat peritoneal mast cells
102. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell
103. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein
104. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo
105. Demonstration of inhibition of mediator release from human mast cells by azatadine base: in vivo and in vitro evaluation
106. Solar urticaria: a case with good therapeutic response to cimetidine
107. Effect of ketotifen and oxatomide on histamine secretion from mast cells
108. Induction of mast cell secretion by parathormone
109. Urticaria in childhood: pathogenesis and management
110. Clinical profile of astemizole: a survey of 50 double-blind trials
111. Electron microscopic evidence for a direct contact between nerve fibers and mast cells